SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001069530-21-000011
Filing Date
2021-03-11
Accepted
2021-03-11 16:59:52
Documents
4
Period of Report
2021-03-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sava-20210311x8k.htm 8-K 42267
2 EX-10.1 sava-20210311xex10_1.htm EX-10.1 276267
3 EX-99.1 sava-20210311xex99_1.htm EX-99.1 10540
4 GRAPHIC sava-20210311xex99_1g001.jpg GRAPHIC 38005
  Complete submission text file 0001069530-21-000011.txt   382847
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29959 | Film No.: 21734027
SIC: 2834 Pharmaceutical Preparations